Search

Your search keyword '"Thibert, Jean‐Baptiste"' showing total 46 results
Start Over Author "Thibert, Jean‐Baptiste"
46 results on '"Thibert, Jean‐Baptiste"'

1. Prophylactic platelet transfusion response in critically ill patients: a prospective multicentre observational study

Author

Reizine, Florian, Le Marec, Sarah, Le Meur, Anthony, Consigny, Maëlys, Berteau, Florian, Bodenes, Laetitia, Geslain, Marie, McQuilten, Zoe, Le Niger, Catherine, Huntzinger, Julien, Seguin, Philippe, Thibert, Jean-Baptiste, Simon, David, Reignier, Jean, Egreteau, Pierre-Yves, Tadié, Jean-Marc, Huet, Olivier, Asfar, Pierre, Ehrmann, Stephan, and Aubron, Cécile

Published
2023
Full Text
View/download PDF

2. Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome (a DESCAR-T study)

Author

Vic, Samuel, Thibert, Jean-Baptiste, Bachy, Emmanuel, Cartron, Guillaume, Gastinne, Thomas, Morschhauser, Franck, Le Bras, Fabien, Bouabdallah, Kamal, Despas, Fabien, Bay, Jacques-Olivier, Rubio, Marie-Thérèse, Mohty, Mohamad, Casasnovas, Olivier, Choquet, Sylvain, Castilla-Llorente, Cristina, Guidez, Stéphanie, Loschi, Michaël, Guffroy, Blandine, Carras, Sylvain, Drieu La Rochelle, Laurianne, Guillet, Mathilde, and Houot, Roch

Published
2024
Full Text
View/download PDF

3. Incentives for plasma donation

Author

Koch, Elena, primary, Leiße, Antonia, additional, Veseli, Besarta, additional, Jensen, Johannes, additional, Spekman, Marloes, additional, Merz, Eva‐Maria, additional, Shehu, Edlira, additional, Thibert, Jean‐Baptiste, additional, Beurel‐Trehan, Antoine, additional, Leblond, Marion, additional, Oesterer, Martin, additional, Kluge, Philipp, additional, Forioso, Donata, additional, and Clement, Michel, additional

Published
2024
Full Text
View/download PDF

4. Umbilical cord blood transplants facilitated by the French cord blood banks network. On behalf of the Agency of Biomedicine, Eurocord and the French society of bone marrow transplant and cell therapy (SFGM-TC)

Author

Rafii, Hanadi, Garnier, Federico, Ruggeri, Annalisa, Ionescu, Irina, Ballot, Caroline, Bensoussan, Danièle, Chabannon, Christian, Dazey, Bernard, De Vos, John, Gautier, Eric, Giraud, Christine, Larghero, Jérome, Cras, Audrey, Mialou, Valérie, Persoons, Virginie, Pouthier, Fabienne, Thibert, Jean-Baptiste, Dalle, Jean-Hugues, Michel, Gerard, Kenzey, Chantal, Volt, Fernanda, Rocha, Vanderson, Bay, Jacques-Olivier, Rubio, Marie-Thérèse, Faucher, Catherine, Marry, Evelyne, and Gluckman, Eliane

Published
2021
Full Text
View/download PDF

5. Impact of COVID-19 pandemic on the use and release of cord blood units facilitated by the French Cord Blood Banks Network: on behalf of the Agency of Biomedicine, Eurocord and the French Society of Bone Marrow Transplant and Cell Therapy (SFGM-TC)

Author

Rafii, Hanadi, Ionescu, Irina, Ruggeri, Annalisa, Garnier, Federico, Ballot, Caroline, Bensoussan, Danièle, Chabannon, Christian, Dazey, Bernard, De Vos, John, Gautier, Eric, Giraud, Christine, Larghero, Jérome, Cras, Audrey, Mialou, Valérie, Persoons, Virginie, Pouthier, Fabienne, Thibert, Jean-Baptiste, Dalle, Jean-Hugues, Michel, Gerard, Sinayoko, Mahamadou, Kenzey, Chantal, Volt, Fernanda, Rocha, Vanderson, Bay, Jacques-Olivier, Rubio, Marie-Thérèse, Robin, Marie, Faucher, Catherine, Marry, Evelyne, and Gluckman, Eliane

Published
2022
Full Text
View/download PDF

7. Suivi des donneurs apparentés : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Author

Polomeni, Alice, Culat-Farhat, Marjorie, Desbrosses, Yohan, Andrianne, Christelle, Ainaoui, Malika, Baillie, Evelyne, Bancillon, Nelly, de Bentzmann, Natacha, Bouya, Salaheddine, Duteil, Elodie, Fraysse, Christine, Issarni, Dominique, Ruscassie, Agnès, Sauze, Séverine, Thibert, Jean-Baptiste, Yakoub-Agha, Ibrahim, and Faucher, Catherine

Published
2020
Full Text
View/download PDF

8. Transfusion dans l’autogreffe et l’allogreffe de cellules souches hématopoïétiques chez l’adulte et l’enfant : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Author

Giraud, Christine, Thibert, Jean-Baptiste, Desbrosses, Yohan, Debiol, Bénédicte, Alsuliman, Tamim, Bardiaux, Laurent, Garban, Frédéric, Huynh, Thi Ngoc Phuong, Samsonova, Olga, Yakoub-Agha, Ibrahim, and Bruno, Bénédicte

Published
2019
Full Text
View/download PDF

12. S14-2 Implémentation de la réduction des pathogènes et extension de la durée de vie des concentrés plaquettaires (CP) en France : étude rétrospective de l’impact de ces mesures sur la délivrance des CP

Author

Thibert, Jean-Baptiste, primary, Malard, Lucille, additional, François, Anne, additional, Richard, Pascale, additional, Kientz, Daniel, additional, Bardiaux, Laurent, additional, Tiberghien, Pierre, additional, and Morel, Pascal, additional

Published
2023
Full Text
View/download PDF

13. P1146: TRANSFUSION NEEDS AFTER CD19 CAR T-CELLS FOR LARGE B-CELL LYMPHOMA: PREDICTIVE FACTORS AND IMPACT ON OUTCOME. A DESCAR-T STUDY.

Author

Vic, Samuel, primary, Thibert, Jean-Baptiste, additional, Bachy, Emmanuel, additional, Cartron, Guillaume, additional, Gastinne, Thomas, additional, Yakoub-Agha, Ibrahim, additional, Le Bras, Fabien, additional, Bouabdallah, Kamal, additional, Despas, Fabien, additional, Olivier Bay, Jacques, additional, Rubio, Marie-Thérèse, additional, Mohty, Mohamad, additional, Olivier Casasnovas, Rene, additional, Choquet, Sylvain, additional, Castilla-Llorente, Cristina, additional, Guidez, Stephanie, additional, Loschi, Michael, additional, Guffroy, Blandine, additional, Carras, Sylvain, additional, Rochelle, Laurianne Drieu La, additional, and Houot, Roch, additional

Published
2023
Full Text
View/download PDF

14. Plasma collection and supply in Europe: Proceedings of an International Plasma and Fractionation Association and European Blood Alliance symposium

Author

Domanović, Dragoslav, primary, von Bonsdorff, Leni, additional, Tiberghien, Pierre, additional, Strengers, Paul, additional, Hotchko, Matthew, additional, O'Leary, Peter, additional, Thibert, Jean‐Baptiste, additional, Magnussen, Karin, additional, Erikstrup, Christian, additional, Spekman, Marloes, additional, Chesneau, Stuart, additional, Jones, Judy, additional, Møller, Bjarne K., additional, Verheggen, Peter, additional, Gogarty, Gerard, additional, Elzaabi, Mazen, additional, de Angelis, Vincenzo, additional, Candura, Fabio, additional, Mali, Polonca, additional, Rossi, Françoise, additional, Rodrigues, Bernardo, additional, Sepetiene, Ramune, additional, Lenzen, Thomas, additional, Walsemann, Stephan, additional, Perry, Robert, additional, Plançon, Jean‐Philippe, additional, So‐Osman, Cynthia, additional, Durand‐Zaleski, Isabelle, additional, Facco, Giuseppina, additional, and Thijssen‐Timmer, Daphne, additional

Published
2023
Full Text
View/download PDF

15. Early and out-of-hospital use of COVID-19 convalescent plasma:An international assessment of utilization and feasibility

Author

Al-Riyami, Arwa Z., Estcourt, Lise, Rahimi-Levene, Naomi, Bloch, Evan M., Goel, Ruchika, Tiberghien, Pierre, Thibert, Jean Baptiste, Bruun, Mie Topholm, Devine, Dana V., Gammon, Richard R., Wendel, Silvano, Toungouz Nevessignsky, Michel, Grubovic Rastvorceva, Rada M., Oreh, Adaeze, Romon, Iñigo, van den Berg, Karin, Kitazawa, Junichi, Patidar, Gopal, So-Osman, Cynthia, Wood, Erica M., Al-Riyami, Arwa Z., Estcourt, Lise, Rahimi-Levene, Naomi, Bloch, Evan M., Goel, Ruchika, Tiberghien, Pierre, Thibert, Jean Baptiste, Bruun, Mie Topholm, Devine, Dana V., Gammon, Richard R., Wendel, Silvano, Toungouz Nevessignsky, Michel, Grubovic Rastvorceva, Rada M., Oreh, Adaeze, Romon, Iñigo, van den Berg, Karin, Kitazawa, Junichi, Patidar, Gopal, So-Osman, Cynthia, and Wood, Erica M.

Abstract

Background and Objectives The use of coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) in the treatment of patients with severe acute respiratory syndrome-2 infection has been controversial. Early administration of CCP before hospital admission offers a potential advantage. This manuscript summarizes current trials of early use of CCP and explores the feasibility of this approach in different countries. Materials and Methods A questionnaire was distributed to the International Society of Blood Transfusion (ISBT) CCP working group. We recorded respondents' input on existing trials on early/outpatient CCP and out-of-hospital (OOH)/home transfusion (HT) practices in their countries and feedback on challenges in initiating home CCP infusion programmes. In addition, details of existing trials registered on clinicaltrials.gov were summarized. Results A total of 31 country representatives participated. Early/OOH CCP transfusion studies were reported in the United States, the Netherlands, Spain and Brazil. There were a total of six published and five ongoing trials on the prophylactic and therapeutic early use of CCP. HT was practised in Australia, the UK, Belgium, France, Japan, Nigeria, the Netherlands, Spain, Italy, Norway, the United States and some provinces in Canada. Thirty-four representatives indicated a lack of OOH CCP or HT in their institutions and countries. Barriers to implementation of OOH/HT included existing legislation, lack of policies pertaining to outpatient transfusion, and associated logistical challenges, including lack of staffing and resources. Conclusion Early administration of CCP remains a potential option in COVID-19 management in countries with existing OOH/HT programmes. Legislation and regulatory bodies should consider OOH/HT practice for transfusion in future pandemics.

Published
2022

18. Impact of COVID-19 pandemic on the use and release of cord blood units facilitated by the French Cord Blood Banks Network: on behalf of the Agency of Biomedicine, Eurocord and the French Society of Bone Marrow Transplant and Cell Therapy (SFGM-TC)

Author

Rafii, Hanadi, primary, Ionescu, Irina, additional, Ruggeri, Annalisa, additional, Garnier, Federico, additional, Ballot, Caroline, additional, Bensoussan, Danièle, additional, Chabannon, Christian, additional, Dazey, Bernard, additional, De Vos, John, additional, Gautier, Eric, additional, Giraud, Christine, additional, Larghero, Jérome, additional, Cras, Audrey, additional, Mialou, Valérie, additional, Persoons, Virginie, additional, Pouthier, Fabienne, additional, Thibert, Jean-Baptiste, additional, Dalle, Jean-Hugues, additional, Michel, Gerard, additional, Sinayoko, Mahamadou, additional, Kenzey, Chantal, additional, Volt, Fernanda, additional, Rocha, Vanderson, additional, Bay, Jacques-Olivier, additional, Rubio, Marie-Thérèse, additional, Robin, Marie, additional, Faucher, Catherine, additional, Marry, Evelyne, additional, and Gluckman, Eliane, additional

Published
2021
Full Text
View/download PDF

19. Early and out‐of‐hospital use of COVID‐19 convalescent plasma: An international assessment of utilization and feasibility.

Author

Al‐Riyami, Arwa Z., Estcourt, Lise, Rahimi‐Levene, Naomi, Bloch, Evan M., Goel, Ruchika, Tiberghien, Pierre, Thibert, Jean‐Baptiste, Bruun, Mie Topholm, Devine, Dana V., Gammon, Richard R., Wendel, Silvano, Toungouz Nevessignsky, Michel, Grubovic Rastvorceva, Rada M., Oreh, Adaeze, Romon, Iñigo, van den Berg, Karin, Kitazawa, Junichi, Patidar, Gopal, So‐Osman, Cynthia, and Wood, Erica M.

Subjects
CONVALESCENT plasma, COVID-19, CANADIAN provinces, BLOOD transfusion
Abstract

Background and Objectives: The use of coronavirus disease 2019 (COVID‐19) convalescent plasma (CCP) in the treatment of patients with severe acute respiratory syndrome‐2 infection has been controversial. Early administration of CCP before hospital admission offers a potential advantage. This manuscript summarizes current trials of early use of CCP and explores the feasibility of this approach in different countries. Materials and Methods: A questionnaire was distributed to the International Society of Blood Transfusion (ISBT) CCP working group. We recorded respondents' input on existing trials on early/outpatient CCP and out‐of‐hospital (OOH)/home transfusion (HT) practices in their countries and feedback on challenges in initiating home CCP infusion programmes. In addition, details of existing trials registered on clinicaltrials.gov were summarized. Results: A total of 31 country representatives participated. Early/OOH CCP transfusion studies were reported in the United States, the Netherlands, Spain and Brazil. There were a total of six published and five ongoing trials on the prophylactic and therapeutic early use of CCP. HT was practised in Australia, the UK, Belgium, France, Japan, Nigeria, the Netherlands, Spain, Italy, Norway, the United States and some provinces in Canada. Thirty‐four representatives indicated a lack of OOH CCP or HT in their institutions and countries. Barriers to implementation of OOH/HT included existing legislation, lack of policies pertaining to outpatient transfusion, and associated logistical challenges, including lack of staffing and resources. Conclusion: Early administration of CCP remains a potential option in COVID‐19 management in countries with existing OOH/HT programmes. Legislation and regulatory bodies should consider OOH/HT practice for transfusion in future pandemics. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

20. Suivi des donneurs apparentés : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Author

POLOMENI, Alice, Culat-Farhat, Marjorie, Desbrosses, Yohan, Andrianne, Christelle, Ainaoui, Malika, Baillie, Evelyne, Bancillon, Nelly, Bentzmann, Natachade, Bouya, Salaheddine, Duteil, Elodie, Fraysse, Christine, Issarni, Dominique, Ruscassie, Agnès, Sauze, Séverine, Thibert, Jean-Baptiste, Yakoub-Agha, Ibrahim, Faucher, Catherine, Service d'hématologie clinique et de thérapie cellulaire [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), and Etablissement français du sang [Rennes] (EFS Bretagne)

Subjects
suivi post-don, donneur apparenté, [SDV]Life Sciences [q-bio], hematopoietic stem cell transplantation, standardisation prise en charge, allogreffe de cellules souches hématopoïetiques, care standardisation, post donation follow-up, related donor
Abstract

International audience; The development of haplo-identical transplants brings to an increased resort to related donation: from 2005 till 2015, this resort increased by 291 %. Beyond the less important financial costs, the related donation also presents the advantage of a faster availability of the donor, avoiding risk of relapse before the procedure.In spite of the existing recommendations, we notice a diversity of the practices among French centers as for the organizational modalities of care, for recruitment criteria, qualification and follow-up of related donors.French Society of Marrow Transplant and Cellular Therapy proposed recommendations concerning the consent and non-qualification criteria of related donors. A multidisciplinary group to facilitate the information about Hematopoietic stem cells donation and transplantation conceived a notebook.In the present article, we propose recommendations for post-donation follow-up, taking into account at the same time medical imperatives and organizational constraints of transplantation teams. Some tools are also presented.; Le développement des greffes haplo-identiques amène à un recours de plus en plus important aux donneurs apparentés : de 2005 à 2015, ce recours s’est accru de 291%. Au-delà des coûts financiers moins importants, le don intrafamilial présente également l’avantage d’une disponibilité plus rapide du donneur, évitant ainsi des risques de rechute avant la procédure.En dépit des recommandations existantes, on constate une diversité des pratiques dans les différents centres français quant aux modalités organisationnelles de prise en charge, aux critères de recrutement, qualification et suivi des donneurs apparentés. La Société Française de Greffe de Moelle et Thérapie Cellulaire a fait des propositions concernant le consentement et les critères de non-qualification des donneurs apparentés de cellules souches hématopoïétiques. Un livret a été conçu par un groupe multidisciplinaire afin de faciliter l’information sur le don et sur l’allogreffe. Dans le présent article, prenant en compte à la fois les impératifs médicaux de surveillance et les contraintes organisationnelles des centres greffeurs, nous proposons des recommandations pour le suivi des donneurs apparentés. Quelques outils (documents d’information, questionnaires) sont présentés.

Published
2019

34. Transfusion dans l’autogreffe et l’allogreffe de cellules souches hématopoïétiques chez l’adulte et l’enfant : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Author

Giraud, Christine, Thibert, Jean-Baptiste, Desbrosses, Yohan, Debiol, Bénédicte, Alsuliman, Tamim, Bardiaux, Laurent, Garban, Frédéric, Huynh, Thi Ngoc Phuong, Samsonova, Olga, Yakoub-Agha, Ibrahim, and Bruno, Bénédicte

Abstract

Les recommandations de la Haute Autorité de santé (HAS) et de l'Agence nationale de sécurité des médicaments (ANSM) sont connues, mais des évolutions sont survenues avec en particulier la suppression du CMV, l'introduction des plaquettes IA -: inactivation par le procédé Intercept (Amotosalem + UVA) permettant de s’affranchir du risque bactérien ainsi que de l’irradiation des plaquettes et la recommandation de donner du plasma VHE négatif en post-allogreffe. Ces mesures ainsi que le spectre plus large de l’IA, sur les arboviroses en particulier sont une réelle avancée en termes de sécurité transfusionnelle. L’état des lieux réalisé auprès des services cliniques et des services de délivrance des produits sanguins labiles (PSL) ainsi que l’étude de la littérature montrent que des améliorations devaient être apportées : la réduction des transfusions de globules rouges avec l’introduction d’un seuil à 7g/dL pendant les hospitalisations en dehors d’un état clinique précaire, la discussion entre les cliniciens et les transfuseurs lors des thrombopénies réfractaires afin d’envisager les différentes étiologies et de définir les protocoles, la nécessité de communication entre les greffeurs et les spécialistes de la transfusion afin de définir les protocoles de transfusions adaptés. L’information et l’éducation des patients sur la transfusion en post-autogreffe ou allogreffe sont importantes. Il doit leur être expliqué qu’ils doivent toujours avoir sur leur personne les documents de groupage sanguin lors de prise en charge d’une hémopathie ou d’une autogreffe et leur document de consignes transfusionnelles lors d’allogreffe ainsi que le document d’information sur les consignes transfusionnelles en post-autogreffe ou allogreffe avec les numéros de téléphone du service de greffe et de l’établissement de transfusion sanguine.

Published
2024
Full Text
View/download PDF

35. A DESCAR-T study of transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome

Author

Vic, Samuel, Thibert, Jean-Baptiste, Bachy, Emmanuel, Cartron, Guillaume, Gastinne, Thomas, Morschhauser, Franck, Le Bras, Fabien, Bouabdallah, Kamal, Despas, Fabien, Bay, Jacques-Olivier, Rubio, Marie-Thérèse, Mohty, Mohamad, Casasnovas, Olivier, Choquet, Sylvain, Castilla-Llorente, Cristina, Guidez, Stéphanie, Loschi, Michaël, Guffroy, Blandine, Carras, Sylvain, Drieu La Rochelle, Laurianne, Guillet, Mathilde, and Houot, Roch

Abstract

•More than half of the patients need transfusion support after CAR T-cell therapy; various factors may affect transfusion needs.•Transfused patients have a poorer outcome with both an increased lymphoma-related mortality and nonrelapse mortality.

Published
2024
Full Text
View/download PDF

36. Greffe de cellules-souches hématopoïétiques – Information et consentement des donneurs et des receveurs : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Author

Bruno, Bénédicte, primary, Thibert, Jean-Baptiste, additional, Bancillon, Nelly, additional, Desbos, Anna, additional, Fawaz, Abir, additional, Fournier, Isabelle, additional, Genty, Carole, additional, Issarni, Dominique, additional, Leveille, Sandrine, additional, Premel, Christelle, additional, Polomeni, Alice, additional, Renault, Myriam, additional, Tarillon, Sylvie, additional, Wallart, Anne, additional, Yakoub-Agha, Ibrahim, additional, and Bordessoule, Dominique, additional

Published
2016
Full Text
View/download PDF

37. Modalités de préparation, cryopréservation, décongélation des cellules souches hématopoïétiques et précautions pour infusion au patient : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Author

Boulanger, Florence, primary, Decot, Véronique, additional, Bulliard, Geneviève, additional, Calmels, Boris, additional, Giraud, Christine, additional, Lacassagne, Marie-Noëlle, additional, Magnani, Alessandra, additional, Pouthier, Fabienne, additional, Thibert, Jean-Baptiste, additional, Tirefort, Yordanka, additional, Yakoub-Agha, Ibrahim, additional, and Baudoux, Etienne, additional

Published
2016
Full Text
View/download PDF

43. [Related donors follow-up: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Author

Polomeni A, Culat-Farhat M, Desbrosses Y, Andrianne C, Ainaoui M, Baillie E, Bancillon N, de Bentzmann N, Bouya S, Duteil E, Fraysse C, Issarni D, Ruscassie A, Sauze S, Thibert JB, Yakoub-Agha I, and Faucher C

Subjects
Allografts, Family, Haplotypes genetics, Histocompatibility, Humans, Informed Consent, Interdisciplinary Communication, Living Donors, Tissue and Organ Procurement methods, Tissue and Organ Procurement standards, Hematopoietic Stem Cell Transplantation, Tissue Donors
Abstract

Since 2010 there has been an exponential increase of the number of transplants performed from related donors. The development of haploidentical transplants increases the resort to related-donation, which presents two main advantages: a less important financial cost and a faster availability of the graft. Standards for mandatory accreditation exist, but the adherence to these recommendations is not optimal: currently, different practices regarding the organizational modalities of care, recruitment criteria, qualification and follow-up of related donors have been observed among French transplant centers. The Francophone Society of Marrow Transplant and Cellular Therapy (SFGM-TC) has developed guidelines for the consent and the non-eligibility criteria for hematopoietic stem cell donors. A multidisciplinary group has devised a booklet as a medium to inform donors about hematopoietic cell donation and transplantation in a clear and accessible language. This paper provides recommendations on post-donation follow-up, taking into account both medical standards and organizational constraints of French centers. Some tools are proposed., (Copyright © 2019 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.)

Published
2020
Full Text
View/download PDF

44. [Modalities for preparation, cryopreservation, thawing of hematopoietic stem cells and precautions for infusion to patient: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Author

Boulanger F, Decot V, Bulliard G, Calmels B, Giraud C, Lacassagne MN, Magnani A, Pouthier F, Thibert JB, Tirefort Y, Yakoub-Agha I, and Baudoux E

Subjects
Belgium, France, Humans, Premedication methods, Premedication standards, Quality Improvement, Societies, Medical, Surveys and Questionnaires, Switzerland, Cryopreservation standards, Hematopoietic Stem Cell Transplantation methods, Hematopoietic Stem Cells
Abstract

To date, despite an existing regulatory framework and standards, there are no true technical recommendations. A survey of 23 cell processing facilities (France, Belgium and Switzerland) has allowed to overview current practices according to cellular products specifications upon arrival at the facility, with modalities for their preparation prior to cryopreservation, storage, thawing and finally for infusion to patient. Data analysis shows great variability of collected volumes and cell concentrations in cellular products. Despite homogeneous practices for handling cells at the facility, methods vary between centers, especially for the choice of cryoprotective solutions and thawing methods. During the workshop, practices have been discussed and summarized to write of recommendations about the following topics: processing and cryopreservation, thawing, bedside precautions (for infusion). This work identifies some improvements in terms of collection, choice of wash solution of thawed cells and validation of the conditions of carriage., (Copyright © 2016. Published by Elsevier Masson SAS.)

Published
2016
Full Text
View/download PDF

45. [Information and consent forms for hematopoietic stem cell transplantation donors and recipients: Guidelines from the Franchophone society of bone marrow transplantation and cellular therapy (SFGM-TC)].

Author

Bruno B, Thibert JB, Bancillon N, Desbos A, Fawaz A, Fournier I, Genty C, Issarni D, Leveille S, Premel C, Polomeni A, Renault M, Tarillon S, Wallart A, Yakoub-Agha I, and Bordessoule D

Subjects
Adult, Child, Family, France, Hematopoietic Stem Cells, Humans, Lymphocytes, Pilot Projects, Validation Studies as Topic, Consensus Development Conferences as Topic, Consent Forms standards, Hematopoietic Stem Cell Transplantation standards, Societies, Medical standards, Tissue Donors
Abstract

Within the context of the SFGM-TC's 6th workshop series on the harmonization of clinical practices, our workshop proposes a standardization of the informed consent process for hematopoietic stem cell donors and recipients leading up to an autologous or allogenic transplantation. All informed consent was for bone marrow or peripheral stem cell donors, and mononuclear/lymphocyte donors according to usual procedures. The informed consent for autologous and allogenic related or unrelated adults and pediatric transplantation patients have been included. A first step has been conducted for collecting in advance the informed consent forms used routinely in all francophone transplantation centers. In a second step, a comprehensive version has been re-written by a multidisciplinary team. For the purposes of understanding the risks and advantages, language has been carefully considered and streamlined. In the third step, texts were sent to stem cell transplantation experts, experts at the French biomedical agency (agence de la biomédecine [ABM]), law specialists, members of the ethical committee of the French society of hematology and several transplant recipients to be edited and proofread., (Copyright © 2016 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.)

Published
2016
Full Text
View/download PDF

46. [General and ethical considerations for the informed consent process: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Author

Thibert JB, Polomeni A, Yakoub-Agha I, and Bordessoule D

Subjects
Bioethical Issues, Communication, France, Hematopoietic Stem Cell Transplantation ethics, Hematopoietic Stem Cell Transplantation legislation & jurisprudence, Humans, Physician-Patient Relations ethics, Societies, Medical, Tissue Donors ethics, Tissue Donors legislation & jurisprudence, Bone Marrow Transplantation ethics, Bone Marrow Transplantation legislation & jurisprudence, Cell- and Tissue-Based Therapy ethics, Consensus Development Conferences as Topic, Informed Consent ethics, Informed Consent legislation & jurisprudence
Abstract

Informed consent is not restricted to clinical research and must be applied to high-risk care such as hematopoietic stem cell transplantation. If standardized informed consent might improve inequalities in medical practices between different transplantation centers, it is strongly recommended that it be adapted with an honest dialogue between physicians and patients and physicians and donors. In an attempt to harmonize clinical practices among French hematopoietic stem cell transplantation centers, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) held its sixth annual workshop series in September 2015 in Lille. This event brought together practitioners from across the country. The purpose of this paper is to highlight the French law concerning patients' rights and ethical practices for an informed consent process to be applied to care or research., (Copyright © 2016 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.)

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results